Allergan, Inc. v. Sandoz Inc.

1 Citing case

  1. Infineum U.S. L.P. v. Chevron Oronite Co.

    No. 2020-1333 (Fed. Cir. Aug. 8, 2022)

    . Relying on Allergan, Inc. v. Sandoz Inc., 726 F.3d 1286, 1293 (Fed. Cir. 2013), the Board concluded that Infineum's unexpected results evidence was not meaningful in view of the fact that Toshikazu "provide[d] a strong reason to use low levels of molybdenum in combination with an organic ashless nitrogen-free friction modifier." Decision, 2019 WL 5806946, at *14.